Amneal Pharmaceuticals, Inc. announced that it has appointed Todd P. Branning as Senior Vice President and Chief Financial Officer, effective January 22, 2019. Mr. Branning will be responsible for leading Amneal's global finance strategies, including oversight for Finance and Accounting, Internal Audit, Investor Relations and Corporate Communications, and Information Technology. Mr. Branning succeeds Bryan Reasons, who will remain with the company through the end of February 2019 to ensure a smooth transition of responsibilities.

Mr. Branning brings more than 25 years of experience leading the finance and accounting strategies as well as corporate financial planning and analysis (FP&A) for public companies, primarily in the pharmaceuticals sector. Most recently, he served as Senior Vice President, Chief Financial Officer, for Teva Pharmaceuticals' multi-billion dollar Global Generic Medicines division.